173 related articles for article (PubMed ID: 15548681)
1. Mechanistic and predictive profiling of 5-Fluorouracil resistance in human cancer cells.
Wang W; Cassidy J; O'Brien V; Ryan KM; Collie-Duguid E
Cancer Res; 2004 Nov; 64(22):8167-76. PubMed ID: 15548681
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil.
de Angelis PM; Fjell B; Kravik KL; Haug T; Tunheim SH; Reichelt W; Beigi M; Clausen OP; Galteland E; Stokke T
Int J Oncol; 2004 May; 24(5):1279-88. PubMed ID: 15067352
[TBL] [Abstract][Full Text] [Related]
3. Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery.
De Angelis PM; Svendsrud DH; Kravik KL; Stokke T
Mol Cancer; 2006 May; 5():20. PubMed ID: 16709241
[TBL] [Abstract][Full Text] [Related]
4. Comparison of gene expression in HCT116 treatment derivatives generated by two different 5-fluorouracil exposure protocols.
De Angelis PM; Kravik KL; Tunheim SH; Haug T; Reichelt WH
Mol Cancer; 2004 Apr; 3():11. PubMed ID: 15109396
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networks.
Wang W; McLeod HL; Cassidy J; Collie-Duguid ES
Cancer Chemother Pharmacol; 2007 May; 59(6):839-45. PubMed ID: 17119966
[TBL] [Abstract][Full Text] [Related]
6. Identification of 5-fluorouracil-inducible target genes using cDNA microarray profiling.
Maxwell PJ; Longley DB; Latif T; Boyer J; Allen W; Lynch M; McDermott U; Harkin DP; Allegra CJ; Johnston PG
Cancer Res; 2003 Aug; 63(15):4602-6. PubMed ID: 12907638
[TBL] [Abstract][Full Text] [Related]
7. Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines.
Chu E; Drake JC; Koeller DM; Zinn S; Jamis-Dow CA; Yeh GC; Allegra CJ
Mol Pharmacol; 1991 Feb; 39(2):136-43. PubMed ID: 1704999
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle perturbation and acquired 5-fluorouracil chemoresistance.
Guo X; Goessl E; Jin G; Collie-Duguid ES; Cassidy J; Wang W; O'Brien V
Anticancer Res; 2008; 28(1A):9-14. PubMed ID: 18383818
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel genes associated with the response to 5-FU treatment in gastric cancer cell lines using a cDNA microarray.
Park JS; Young Yoon S; Kim JM; Yeom YI; Kim YS; Kim NS
Cancer Lett; 2004 Oct; 214(1):19-33. PubMed ID: 15331170
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle regulation of the G0/G1 transition in 5-fluorouracil-sensitive and -resistant human colon cancer cell lines.
McGinn CJ; Pestalozzi BC; Drake JC; Glennon MC; Kunugi K; Otterson G; Allegra CJ; Johnston PG; Kinsella TJ
Cancer J; 2000; 6(4):234-42. PubMed ID: 11038143
[TBL] [Abstract][Full Text] [Related]
11. Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines.
Johnston PG; Drake JC; Trepel J; Allegra CJ
Cancer Res; 1992 Aug; 52(16):4306-12. PubMed ID: 1643628
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomic dissection of resistance to thymidylate synthase inhibitors.
Wang W; Marsh S; Cassidy J; McLeod HL
Cancer Res; 2001 Jul; 61(14):5505-10. PubMed ID: 11454699
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance.
Shin YK; Yoo BC; Chang HJ; Jeon E; Hong SH; Jung MS; Lim SJ; Park JG
Cancer Res; 2005 Apr; 65(8):3162-70. PubMed ID: 15833846
[TBL] [Abstract][Full Text] [Related]
14. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T
Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin.
Mariadason JM; Arango D; Shi Q; Wilson AJ; Corner GA; Nicholas C; Aranes MJ; Lesser M; Schwartz EL; Augenlicht LH
Cancer Res; 2003 Dec; 63(24):8791-812. PubMed ID: 14695196
[TBL] [Abstract][Full Text] [Related]
16. Role of IKK and oscillatory NFkappaB kinetics in MMP-9 gene expression and chemoresistance to 5-fluorouracil in RKO colorectal cancer cells.
Fukuyama R; Ng KP; Cicek M; Kelleher C; Niculaita R; Casey G; Sizemore N
Mol Carcinog; 2007 May; 46(5):402-13. PubMed ID: 17186550
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
[TBL] [Abstract][Full Text] [Related]
18. [Establishment of a multidrug-resistant cell line BEL-7402/5-FU of human hepatocellular carcinoma and its biological characteristics].
Gu W; Zhang YN; Li B; Han J; Cheng BB; Ling CQ
Zhong Xi Yi Jie He Xue Bao; 2006 May; 4(3):265-70. PubMed ID: 16696913
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells.
Akao Y; Noguchi S; Iio A; Kojima K; Takagi T; Naoe T
Cancer Lett; 2011 Jan; 300(2):197-204. PubMed ID: 21067862
[TBL] [Abstract][Full Text] [Related]
20. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
